Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB

Abdul Bari Muhammad1,2, Bowen Xing3, Chengyang Liu4

  • 1Abramson Family Cancer Research Institute, Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

Menin and PRMT5 suppress GLP1R transcript levels and key signaling pathways. A menin inhibitor reverses this suppression, potentially promoting pancreatic beta-cell proliferation for diabetes treatment.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Menin (encoded by MEN1) is a scaffold protein regulating gene transcription and suppressing pancreatic beta-cell proliferation.
  • Glucagon-like-peptide-1 (GLP1) influences beta-cell mass and glucose homeostasis, but its interaction with menin is unclear.
  • Menin's role in diabetes pathogenesis and its potential modulation for therapeutic benefit warrant investigation.

Purpose of the Study:

  • To investigate the crosstalk between menin and GLP1 signaling in pancreatic beta-cells.
  • To determine if menin influences GLP1 receptor (GLP1R) expression and downstream signaling pathways.
  • To evaluate the therapeutic potential of menin inhibition in promoting beta-cell proliferation.

Main Methods:

  • Assessed menin and PRMT5 effects on GLP1R transcript levels.
  • Investigated GLP1-induced phosphorylation of FOXO1 and CREB, and menin's role in this process.
  • Utilized a small-molecule menin inhibitor to reverse menin-mediated suppression.
  • Examined the impact of menin inhibition on beta-cell proliferation marker Ki67 in pancreatic islets.

Main Results:

  • Menin and PRMT5 were found to suppress GLP1R transcript levels.
  • Menin inhibits GLP1-induced and PKA-mediated phosphorylation of FOXO1 and CREB.
  • Menin inhibition reversed suppression of FOXO1 and CREB phosphorylation, increasing FOXO1 levels and affecting CREB target genes.
  • Ex vivo treatment with a menin inhibitor increased Ki67 levels in mouse and human pancreatic islets.

Conclusions:

  • Menin and PRMT5 suppress GLP1R expression and key signaling pathways (FOXO1, CREB phosphorylation) involved in beta-cell function.
  • A menin inhibitor can reverse menin-mediated suppression, suggesting a therapeutic strategy to induce beta-cell proliferation.
  • Targeting menin offers a potential approach for managing diabetes by enhancing beta-cell mass.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.8K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K